Statistics for Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Total visits
| views | |
|---|---|
| Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 | 24 |
Total visits per month
| views | |
|---|---|
| July 2025 | 1 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 3 |
| January 2026 | 2 |
File Visits
| views | |
|---|---|
| Vaccine effectiveness against COVID-19 hospitalisation in adults.pdf | 22 |
Top country views
| views | |
|---|---|
| United States | 9 |
| India | 4 |
| United Kingdom | 2 |
| Japan | 2 |
| Mongolia | 2 |
| Belgium | 1 |
| China | 1 |
| Greece | 1 |
| Iran | 1 |
| Portugal | 1 |
Top city views
| views | |
|---|---|
| Bengaluru | 4 |
| Brussels | 1 |
| Cornelius | 1 |
| Los Angeles | 1 |